kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the URGN dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for URGN.

URGN

UroGen Pharma Ltd.
Healthcare · Biotechnology
$102.12 sample
-0.79 (-0.77%) 1D
☆ Watch
Market cap
$662.1B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-23
Alerts
8
Price$102.12 -13.99% 3M daily closessample
119.78101.95
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 23SECForm 144 filed
  • Oct 20SECDEF 14A filed
  • Oct 15INSInsider buy: General Counsel
  • Oct 06SEC10-Q filed
  • Sep 25INSInsider sell: Chief Financial Officer
  • Sep 21SECForm 144 filed
  • Sep 14SECForm 144 filed
  • Sep 08INSInsider buy: 10% owner
Sign up to see the real URGN record →

Company facts

SEC EDGAR registration
Name
UroGen Pharma Ltd.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
-14sample, -100 to +100
Reporting currency
USD

Who is positioning in URGN

sample
Insiders
10 insider transactions over 90 days, net selling, $252.4M
Congress
2 members traded over 90 days
Institutions · 13F
37 funds hold $8.7B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$41.0B +16.3% y/y
Q4 2024Q3 2026
Inventory$23.4B +8.6% y/y
Q4 2024Q3 2026
Accounts receivable$18.1B +8.7% y/y
Q4 2024Q3 2026
Total debt$49.6B +19.6% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$139.1B -10.6% 3M
Sample peer B
$72.9B -11.2% 3M
Sample peer C
$85.3B -7.2% 3M
Sample peer D
$569.5B +8.0% 3M
Sample peer E
$250.8B -7.9% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not URGN's real figure. Nothing here is investment advice.